Nuveen Asset Management

Nuveen Asset Management Portfolio holdings

AUM $354B
1-Year Return 34.48%
 

Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.

This Quarter Return
-3.74%
1 Year Return
+34.48%
3 Year Return
+60.43%
5 Year Return
+189.89%
10 Year Return
+390.34%
AUM
$309B
AUM Growth
-$29.4B
Cap. Flow
-$6.05B
Cap. Flow %
-1.96%
Top 10 Hldgs %
22.53%
Holding
3,386
New
44
Increased
1,590
Reduced
1,481
Closed
89

Sector Composition

1 Technology 24.82%
2 Financials 12.45%
3 Healthcare 12.44%
4 Consumer Discretionary 11.85%
5 Industrials 8.4%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SKYT icon
3176
SkyWater Technology
SKYT
$491M
$176K ﹤0.01%
16,296
KLTR icon
3177
Kaltura
KLTR
$226M
$175K ﹤0.01%
89,435
+66,337
+287% +$130K
DSP icon
3178
Viant Technology
DSP
$167M
$174K ﹤0.01%
26,181
VINC
3179
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$173K ﹤0.01%
2,024
-1,952
-49% -$167K
ALGS icon
3180
Aligos Therapeutics
ALGS
$78.8M
$172K ﹤0.01%
2,410
-961
-29% -$68.6K
INZY
3181
DELISTED
Inozyme Pharma
INZY
$172K ﹤0.01%
43,574
+1,313
+3% +$5.18K
RPID icon
3182
Rapid Micro Biosystems
RPID
$120M
$171K ﹤0.01%
22,324
+11,518
+107% +$88.2K
AMLX icon
3183
Amylyx Pharmaceuticals
AMLX
$910M
$170K ﹤0.01%
+13,230
New +$170K
OCFT
3184
OneConnect Financial Technology
OCFT
$281M
$160K ﹤0.01%
11,350
-880
-7% -$12.4K
ALPN
3185
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$160K ﹤0.01%
18,446
ONCR
3186
DELISTED
Oncorus, Inc.
ONCR
$159K ﹤0.01%
96,208
+2,957
+3% +$4.89K
CELC icon
3187
Celcuity
CELC
$2.36B
$155K ﹤0.01%
18,884
HYRE
3188
DELISTED
HyreCar Inc. Common Stock
HYRE
$154K ﹤0.01%
55,388
+1,969
+4% +$5.48K
SBDS
3189
Solo Brands, Inc.
SBDS
$18.8M
$152K ﹤0.01%
17,769
NPCE icon
3190
Neuropace
NPCE
$322M
$150K ﹤0.01%
17,850
ETNB icon
3191
89bio
ETNB
$1.32B
$149K ﹤0.01%
38,906
-17,234
-31% -$66K
FTHM icon
3192
Fathom Holdings
FTHM
$55.4M
$149K ﹤0.01%
12,844
VEL icon
3193
Velocity Financial
VEL
$736M
$148K ﹤0.01%
13,428
COCO icon
3194
Vita Coco
COCO
$2.19B
$146K ﹤0.01%
16,344
XGN icon
3195
Exagen
XGN
$213M
$142K ﹤0.01%
17,388
NEE.PRP
3196
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
0
-$150K
SNSE icon
3197
Sensei Biotherapeutics
SNSE
$10.5M
$133K ﹤0.01%
2,623
+46
+2% +$2.33K
TRDA icon
3198
Entrada Therapeutics
TRDA
$201M
$130K ﹤0.01%
13,872
LOGC
3199
DELISTED
ContextLogic
LOGC
$130K ﹤0.01%
+2,031
New +$130K
RVYL icon
3200
Ryvyl
RVYL
$8.63M
$127K ﹤0.01%
4,052